The ACE gene polymorphism is associated with the incidence of gastric cancer among H. pylori seropositive subjects with atrophic gastritis

Asian Pacific Journal of Cancer Prevention

Volumn 6, Issue 4, 2005, Pages 464-467

  Goto, Yasuyuki ^a   Ando, Takafumi ^a   Nishio, Kazuko ^a   Ishida, Yoshiko ^a   Kawai, Sayo ^a   Goto, Hidemi ^a   Hamajima, Nobuyuki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ACE polymorphisms; Gastric cancer risk

Indexed keywords

BACTERIUM ANTIBODY; DIPEPTIDYL CARBOXYPEPTIDASE; PEPSINOGEN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BLOOD; CASE CONTROL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETICS; HELICOBACTER PYLORI; HUMAN; IMMUNOLOGY; INCIDENCE; MALE; METABOLISM; MIDDLE AGED; STOMACH TUMOR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; FEMALE; GASTRITIS, ATROPHIC; HELICOBACTER PYLORI; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PEPSINOGENS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; STOMACH NEOPLASMS;

EID: 33646706851     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Arrieta O, Guevara P, Escobar E, et al (2005). Blockage of angiotensin II type 1 receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma. Br J Cancer, 92, 1247-52.
2. Bauvois B (2004). Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis? Oncogene, 23, 317-29
3. Blaser MJ (1999). Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis, 179, 1523-30.
4. Correa P, Haenzel W, Cuello C, et al (1975). A model for gastric cancer epidemiology. Lancet, 2, 58-9.
5. Deshayes D, Nahmias C (2005). Angiotensin receptors: a new role in cancer? Trends Endocrinol Metab, 16, 293-9.
6. Dunbier A, Guilford P (2001). Hereditary diffuse gastric cancer. Adv Cancer Res, 83, 55-65.
7. El-Omar EM, Carrington M, Chow WH, et al (2000). Interleukin- 1 polymorphisms associated with increased risk of gastric cancer. Nature, 404, 398-402.
8. El-Omar EM, Chow WH, Rabkin CS (2001). Gastric cancer and H. pylori: Host genetics open the way. Gastroenterology, 121, 1002-4.
9. El-Omar EM, Rabkin CS, Gammon MD, et al (2003). Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology, 124, 1193-201.
10. Fujimoto Y, Sasaki T, Tsuchida A, et al (2001). Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. FEBS Lett, 495, 197-200.
11. Gonzalez CA, Sala N, Capella G (2002). Genetic susceptibility and gastric cancer risk. Int J Cancer, 100, 249-60.
12. Goto Y, Ando T, Yamamoto K, et al (2006). Association between serum pepsinogens and polymorphism of PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese. Int J Cancer, 118, 203-8.
13. Greco S, Muscella A, Elia M G, et al (2003). Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells. J Cell Physiol, 196, 370-7.
14. Haiman CA, Henderson SO, Bretsky P, et al (2003). Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: The multiethnic cohort. Cancer Res, 63, 6984-7.
15. Juillerat-Jeanneret L, Celerier J, Chapuis Bernasconi C, et al (2004). Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma. Br J Cancer, 90, 1059-68.
16. Katsuda N, Hamajima N, Tamakoshi A, et al (2003). Helicobacter pylori seropositivity and the myeloperoxidase G-463A polymorphism in combination with interleukin 1B C-31T in Japanese health checkup examinees. Jpn J Clin Oncol, 33, 192-7.
17. Kitahara F, Shimazaki R, Sato T, et al (1998). Sever atrophic gastritis with Helicobacter pylori infection and gastric cancer. Gastric Cancer, 1, 118-24.
18. Koh W, Yuan J, Sun C, et al (2003). Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res, 63, 573-8.
19. Kowa H, Fusayama E, Ijiri T, et al (2005). Association of the insertion/deletion polymorphism of the angiotensin Iconverting enzyme gene in patients of migraine with aura. Neurosci Lett, 374, 129-31.
20. Machado JC, Pharoah P, Sousa S, et al (2001). Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology, 121, 823-9.
21. Machado JC, Figueiredo C, Canedo P, et al (2003). A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology, 125, 364-71.
22. Ministry of Health, Labor and Welfare (2003). Journal of Health and Welfare Statistics 2003. Tokyo: Health and Welfare Statistics Association.
23. Muscella A, Greco S, Elia MG, et al (2002). Angiotensin II stimulation of Na+/K+ ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells. J Endocrinol, 173, 315-23.
24. Neugut AI, Hayek M, Howe G (1996). Epidemiology of gastric cancer. Semin Oncol, 23, 281-91.
25. Rigat B, Hubert C, Alhenc-Gelas F, et al (1990). An insertion/ deletion polymorphism of the human angiotensin cinverting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest, 86, 1343-6.
26. Rigat B, Hubert C, Corvol P, et al (1992). PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acid Res, 20, 1433.
27. Röcken C, Lendeckel U, Dierkes J, et al (2005). The number of lymph node metastases in gastric cancer correlates with the angiotensin Iñconverting enzyme gene insertion/deletion polymorphism. Clin Cancer Res, 11, 2526-30.
28. Stewart BW, Kleihues P (2003). World Cancer Report. Lyon: IARC Press.
29. Stadtlander CT, Waterbor JW (1999). Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis, 20, 2195-208.
30. Tahara E (1993). Molecular mechanisms of stomach carcinogenesis. J Cancer Res Clin Oncol, 119, 265-72.
31. Uemura H, Ishiguro H, Nakaigawa N, et al (2003). Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor. Mol Cancer Ther, 2, 1139-47.
32. Werner M, Becker KF, Keller G, et al (2001). Gastric carcinoma: Pathomorphology and molecular pathology. J Cancer Res Clin Oncol, 127, 207-16.
33. Yasui W, Yokozaki H, Fujimoto J, et al (2000). Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol, 35, 111-5.